Xuemin (Jim) Jiang, PhD

Director, Clinical Pharmacology @ Lyndra Therapeutics

About Xuemin (Jim) Jiang, PhD

Xuemin (Jim) Jiang, PhD, serves as the Director of Clinical Pharmacology at Lyndra Therapeutics, bringing over 14 years of expertise in clinical pharmacokinetics and pharmacodynamics. His previous roles include senior positions at Novartis and Alnylam Pharmaceuticals, as well as academic experience at the University of Sydney and University of Chicago Medicine.

Current Role at Lyndra Therapeutics

Xuemin (Jim) Jiang serves as the Director of Clinical Pharmacology at Lyndra Therapeutics, a position he has held since 2021. In this role, he focuses on advancing the understanding of clinical pharmacology to support the development of innovative drug delivery systems. His expertise in pharmacokinetics and pharmacodynamics contributes to the strategic direction of clinical studies and regulatory submissions.

Previous Experience in Clinical Pharmacology

Prior to joining Lyndra Therapeutics, Jiang held several significant positions in the field of clinical pharmacology. He worked as a Senior Investigator I in DMPK - Clinical PKPD at Novartis from 2010 to 2017, and as Associate Director of Clinical Pharmacology and Pharmacometrics at Alnylam Pharmaceuticals from 2017 to 2019. His experience also includes a role as Staff Scientist in DMPK - Pharmacokinetics at Covance from 2007 to 2010.

Educational Background and Expertise

Jiang earned his Doctor of Philosophy (PhD) in Clinical Pharmacokinetics and Pharmacodynamics from the University of Sydney, where he studied from 1999 to 2004. His academic background laid the foundation for his extensive expertise in clinical pharmacokinetics, pharmacodynamics, drug metabolism and pharmacokinetics (DMPK), and pharmacometrics, totaling over 14 years of experience in the industry.

Postdoctoral Experience

Xuemin Jiang has completed multiple postdoctoral fellowships that enhanced his research capabilities. He served as a Postdoctoral Fellow in Clinical PKPD at the University of Sydney from 2003 to 2006 and later at the University of Chicago Medicine in Clinical Pharmacology from 2006 to 2007. These experiences contributed to his deep understanding of clinical pharmacology and its applications in drug development.

Technical Proficiencies

Jiang possesses hands-on experience with various software tools essential for pharmacometric analysis, including NONMEM, Phoenix, and R. His proficiency in these tools supports his work in clinical pharmacology, enabling him to conduct complex data analyses and modeling to inform drug development processes.

People similar to Xuemin (Jim) Jiang, PhD